Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GENNEX LAB.   MYLAN
EQUITY SHARE DATA
    GENNEX LAB.
Mar-23
MYLAN
Dec-18
GENNEX LAB./
MYLAN
5-Yr Chart
Click to enlarge
High Rs93,967-   
Low Rs52,184-   
Sales per share (Unadj.) Rs3.41,825.4-  
Earnings per share (Unadj.) Rs0.349.6-  
Cash flow per share (Unadj.) Rs0.3391.3-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs4.51,974.7-  
Shares outstanding (eoy) m176.64514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.11.7 122.9%   
Avg P/E ratio x25.062.0 40.2%  
P/CF ratio (eoy) x21.07.9 267.7%  
Price / Book Value ratio x1.51.6 98.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,2291,582,214 0.1%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m790-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m593939,158 0.1%  
Other income Rs m400-   
Total revenues Rs m633939,158 0.1%   
Gross profit Rs m47243,019 0.0%  
Depreciation Rs m9175,847 0.0%   
Interest Rs m1445,170 0.0%   
Profit before tax Rs m6422,002 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15-3,500 -0.4%   
Profit after tax Rs m4925,502 0.2%  
Gross profit margin %7.925.9 30.6%  
Effective tax rate %22.8-15.9 -143.2%   
Net profit margin %8.32.7 305.3%  
BALANCE SHEET DATA
Current assets Rs m487524,425 0.1%   
Current liabilities Rs m295382,364 0.1%   
Net working cap to sales %32.315.1 213.5%  
Current ratio x1.61.4 120.3%  
Inventory Days Days484 4.8%  
Debtors Days Days57,912,58993 62,061,495.1%  
Net fixed assets Rs m835182,181 0.5%   
Share capital Rs m180500 36.0%   
"Free" reserves Rs m6230-   
Net worth Rs m8041,015,998 0.1%   
Long term debt Rs m1631,096,588 0.0%   
Total assets Rs m1,3222,725,301 0.0%  
Interest coverage x5.71.5 383.8%   
Debt to equity ratio x0.21.1 18.8%  
Sales to assets ratio x0.40.3 130.3%   
Return on assets %4.72.6 183.1%  
Return on equity %6.12.5 244.0%  
Return on capital %8.03.2 251.5%  
Exports to sales %42.10-   
Imports to sales %13.60-   
Net fx Rs m1640-   
CASH FLOW
From Operations Rs m237195,157 0.1%  
From Investments Rs m-383-100,875 0.4%  
From Financial Activity Rs m210-90,916 -0.2%  
Net Cashflow Rs m641,617 3.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare GENNEX LAB. With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare GENNEX LAB. With: BETA DRUGS   IOL CHEMICALS & PHARM.  DR. REDDYS LAB  WYETH  BANDARAM PHARMA PACKTECH  



Today's Market

Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9% Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9%(10:30 am)

Asian stocks fell on Thursday as disappointing earnings forecasts from Facebook parent Meta Platforms hammered tech shares, while the yen's slump past 155 per dollar.